AnaptysBio Inc diskutieren
AnaptysBio Inc
WKN: A2AJ8C / Symbol: ANAB / Name: AnaptysBio / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
45,20 €
0,00 %
AnaptysBio (NASDAQ:ANAB) was given a new $70.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its price target lowered by analysts at HC Wainwright from $52.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by HC Wainwright from $51.00 to $66.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by Barclays PLC from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Abercrombie + Fitch A diskutieren, Abercrombie + Fitch A